DFTX filings
Corporate insider profile
Matthew T. Wiley Filing Activity
Latest reported as Chief Commercial Officer of Definium Therapeutics, Inc. (DFTX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$129,101.01
- Latest transaction
- Jun 25, 2026
Affiliated corporations
Reported company relationships
Transaction history
